[1] |
LIU Lijing, QIAN Hong, MENG Qingxin, ZHANG Xiang, HE Bin, HE Jianbin, WEI Yingmin.
Sinomenine inhibits oxidative stress and pulmonary fibrosis by activating the Keap1/Nrf2 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 979-987.
|
[2] |
LI Yating, YUE Hongmei, LIU Miaomiao, XU Jinhui, WU Xingdong, ZHU Haobin.
The possibility of phosphodiesterase 4 inhibitors as drug therapy for idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 818-823.
|
[3] |
LIU Nanyu, YUE Hongmei, SONG Peipei, WEI Jifang, WEI Yaqian, XIE Yingying, WANG Jiaqi .
PDE4 inhibitors serve as therapeutic targets for pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 355-360.
|
[4] |
WANG Jie, LI Long, CHEN Feng, LIU Shengfei.
Research progress of metformin in the pathogenesis of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 235-240.
|
[5] |
WEI Feng, HE Yang, FAN Zhiqiang, LIU Shikun, OUYANG Linqi.
Inhibitory effect of flufenidone on TGF-β1/Smads pathway in hepatocytes of rats with diethylnitrosamine (DEN)-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 739-746.
|
[6] |
LI Xueheng, LI Long.
Research progress on the relationship between melatonin and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 715-720.
|
[7] |
WEI Jifang, YUE Hongmei, LIU Nanyu, SONG Peipei, XIE Yingying, WANG Jiaqi, WEI Yaqian.
Research progress on the relationship between thyroid hormone and idiopathic pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 307-313.
|
[8] |
NIU Pilian, FAN Yongxin, LU Furui, ZHOU Xuezhang, BAI Mingsheng.
Effects of liquorice extract on cardiac fibroblasts fibrosis induced by TGF-β1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 129-135.
|
[9] |
JIA Chengwen, JIANG Hugang, GAO Xiang, HAN Jinyan, XU Xiaodong, ZHAO Xinke.
Interventional effect of Radix Angelica Sinensis and Radix Hedysari ultrafiltration on miR-21-5P targeting TGF-β1-mediated radiation-induced myocardial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1221-1230.
|
[10] |
ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong.
Molecular mechanism and treatment of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
|
[11] |
HAO Wei, ZUO Dongze, ZHANG Junxiu, JIANG Lili, XIONG Ying, YANG Jieren.
Effects of metformin on epithelial-mesenchymal transition of rat alveolar epithelial type II cells induced by TGF-β1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 744-752.
|
[12] |
LIU Peng, ZHAO Hailing, SHEN Zhengri, WANG Chen, WANG Yun, QIU Xinping, LI Ping.
Tangshen formula promotes cellular cholesterol efflux in HG-induced mTECs by suppression of TGF-β1/Smad3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(1): 1-9.
|
[13] |
ZHANG Junxiu, SHEN Yuanyuan, YANG Jieren, ZHENG Shuguo, HAO Wei.
Inhibition of PI3K/AKT signaling pathway by sesamin and vitamin E improves left ventricular fibrosis in spontaneously hypertensive rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(11): 1214-1222.
|
[14] |
MA Yuandong, HUANG Zuwei, AN Pei, XIE Xiaofei, LIU Xiaocai, MAO Lingzhe.
Effects of ambroxol hydrochloride on pulmonary fibrosis in rats and its effect on TGF-β/Smad/ERK signal transduction pathway and Th17/Treg cell imbalance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1201-1208.
|
[15] |
FENG Zheng-quan, LIN Xiao-yang, HAO Wan-rong.
Effect of tetrastigma hemsleyanum diels et gilg flavone on the immunosuppressive associated cytokines in Lewis lung cancer mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 275-279.
|